See every side of every news story
Published loading...Updated

Atara Biotherapeutics Sees Its Stock Price Rise

Summary by labusinessjournal.com
The announcement by Atara Biotherapeutics Inc. that it was raising $36 million through a registered direct offering sat well with investors. Thousand Oaks-based drug company made the announcement after the market closed on Sept. 3. The following day the stock rose nearly 33% to end the day at $9.05. The increase in share price continued a trend of sorts in play for Atara since its 1:25 stock split on June 20. On that day the share price closed a…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

labusinessjournal.com broke the news in on Monday, September 9, 2024.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.